« Previous
Next »
Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 6
, Pages 356-359
, November 2008
Titrated Initiation of Acetylsalicylic Acid-Dipyridamole Therapy Reduces Adverse Effects and Improves Tolerance in Patients With Stroke
References
- European stroke prevention study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1–13
- . Aspirin and dipyridamole versus aspirin alone after cerebral ischemia of arterial origin (ESPRIT): Randomized controlled trial. Lancet. 2006;367:1665–1673
- Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia. 2006;26:925–933
- Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. Neurology. 2004;63:1099–1101
- Dipyridamole and headache–a pilot study of initial dose titration. J Neurol Sci. 2004;223:179–184
- . Dose titration to reduce dipyridamole-related headache. Cerebrovasc Dis. 2006;22:258–262
- . Rapid development of tolerance to dipyridamole-associated headaches. Br J Clin Pharmacol. 1999;48:750–755
Supported through unrestricted educational grants from Boehringer Ingelheim, Canada (N. Pageau, S. Medic, M. Sabih).
PII: S1052-3057(08)00089-X
doi: 10.1016/j.jstrokecerebrovasdis.2008.04.003
© 2008 National Stroke Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Stroke & Cerebrovascular Diseases
Volume 17, Issue 6
, Pages 356-359
, November 2008
